FDA Adverse Event Injury Summary report: N

RX ACCUNET EMBOLIC PROTECTION SYSTEM

MDR report key: 2091491 · Received May 17, 2011

Report

Report Number
2024168-2011-03516
Event Type
Injury
Date Received
May 17, 2011
Date of Event
April 26, 2011
Report Date
April 27, 2011
Manufacturer
AV-TEMECULA-CT
Product Code
NTE
PMA / PMN Number
K052166
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. THERE WAS NO REPORTED PRODUCT DEFICIENCY. THE REPORTED PATIENT EFFECTS OF CEREBROVASCULAR ACCIDENT (STROKE) AND WEAKNESS ARE LISTED IN THE PRODUCT INSTRUCTION FOR USE AS POTENTIAL ADVERSE EFFECTS. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECTS AND THE RELATIONSHIP TO THE DEVICE, IF ANY, CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE, DESIGN OR LABELING.

Description of Event or Problem · 1

IT WAS REPORTED THAT DURING A LEFT INTERNAL CAROTID STENTING PROCEDURE AFTER THE RX ACCUNET EMBOLIC PROTECTION DEVICE CROSSED THE TARGET LESION, THE PATIENT EXPERIENCED A STROKE WITH RIGHT SIDED WEAKNESS AND GLOBAL APHASIA. TREATMENT INCLUDED EPTIFIBATIDE INFUSION. THE WEAKNESS RESOLVED AT THE END OF THE PROCEDURE AND THE APHASIA IS GREATLY IMPROVED AT POST PROCEDURE DAY TWO. THE PATIENT'S CONDITION RESOLVED TO BASELINE AND THE PATIENT WAS DISCHARGED HOME ON (B)(6) 2011. THOUGH REQUESTED THERE WAS NO ADDITIONAL INFORMATION PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 RX ACCUNET EMBOLIC PROTECTION SYSTEM EMBOLIC PROTECTION SYSTEM NTE AV-TEMECULA-CT 1010461

Patients

Seq Age Sex Outcome Treatment
1 70 YR Hospitalization| R| S STENT: RX ACCULINK